First reported at 16 shares this quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2023-03-31 | 0 |
| 2023-06-30 | 0 |
| 2024-03-31 | 26 |
| 2024-06-30 | 27 |
| 2024-09-30 | 17 |
| 2024-12-31 | 15 |
| 2025-03-31 | 10 |
| 2025-06-30 | 0 |
| 2025-09-30 | 5345 |
| 2025-12-31 | 2276 |
| 2026-03-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q1 2026 | Reduced | 0 | -2,253 (-100.0%) | 0 | $0 | 2026-05-13 | |
| Q4 2025 | Added | 2,253 | +115 (5.4%) | < 0.01% | $2,276 | 2026-02-11 | |
| Q3 2025 | New | 2,138 | +2,138 (0.0%) | < 0.01% | $5,345 | 2025-11-07 | |
| Q2 2025 | Reduced | 0 | -8 (-100.0%) | 0 | $0 | 2025-08-12 | |
| Q1 2025 | Reduced | 8 | -1 (-11.1%) | < 0.01% | $10 | 2025-05-12 | |
| Q4 2024 | Unchanged | 9 | 0 (0.0%) | < 0.01% | $15 | 2025-02-12 | |
| Q3 2024 | Reduced | 9 | -1 (-10.0%) | < 0.01% | $17 | 2024-11-08 | |
| Q2 2024 | Added | 10 | +1 (11.1%) | < 0.01% | $27 | 2024-08-12 | |
| Q1 2024 | New | 9 | +9 (0.0%) | < 0.01% | $26 | 2024-05-10 | |
| Q2 2023 | Reduced | 0 | -16 (-100.0%) | 0 | $0 | 2023-08-11 | |
| Q1 2023 | New | 16 | +16 (0.0%) | 0 | $0 | 2023-05-11 |
Who else reported the position
14 managers reported ANEBULO PHARMACEUTICALS INC for Q1 2023.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| 22NW LP | Unchanged | 5,066,290 | 0 | 9.03% | $14,692,241 | 8 qtrs |
| LVW Advisors LLC | Reduced | 673,331 | -583 | 0.38% | $1,952,660 | 4 qtrs |
| Nantahala Capital Management LLC | Unchanged | 511,073 | 0 | 0.11% | $1,482,112 | 3 qtrs |
| MANGROVE PARTNERS | Unchanged | 399,219 | 0 | 0.08% | $1,157,735 | 8 qtrs |
| Ikarian Capital LLC | Unchanged | 156,203 | 0 | 0.1% | $462,360 | 8 qtrs |
| BOOTHBAY FUND MANAGEMENT LLC | Unchanged | 17,319 | 0 | < 0.01% | $50,225 | 8 qtrs |
| BlackRock Inc | Added | 7,533 | +240 | < 0.01% | $21,846 | 8 qtrs |
| Tower Research Capital LLC TRC | Added | 5,107 | +1,510 | < 0.01% | $15,000 | 8 qtrs |
| WELLS FARGO & COMPANY MN | Added | 55 | +1 | < 0.01% | $160 | 8 qtrs |
| Praetorian Capital Management LLC | Reduced | 0 | -180,005 | 0 | $0 | 2 qtrs |
Filing details and methodology As reported
- Report period
- March 31, 2023
- Filed
- May 11, 2023
- Filing type
- 13F-HR
- Position type
- COMMON
Voting authority reported
- Sole
- 16
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.